Johnson & Johnson said on Wednesday that its medical device unit underperformed in the second quart...
J&J medtech miss overshadows earnings beat
Johnson & Johnson said on Wednesday that its medical device unit underperformed in the second quarter, even as strong sales of Tremfya for autoimmune...
Author: Reuters
Read Original Article